1-7 of 7
Carla M. Mamolo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preliminary Exploration of Patient Perspectives on Tyrosine Kinase Inhibitors for the Treatment of Chronic-Phase Chronic Myeloid Leukemia

Bradley Mason, Carla M. Mamolo, PhD, Chloe Johnson, Andrea Viqueira, MD, Adam Gater, Alexander Russell-Smith, Sophi Tatlock, Richa Shah, PharmD, RPh, Joseph C Cappelleri, PhD MPH, MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 5918.
https://doi.org/10.1182/blood-2019-123444
Published: 2019
Journal Articles

Impact of Diarrhea on Health-Related Quality of Life: Analysis of the Phase 3 BFORE Trial of Bosutinib Vs Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Tim H Brümmendorf, MD, Carla M. Mamolo, PhD, Arlene Reisman, Andrew G Bushmakin, Joseph C Cappelleri, PhD MPH, MS, Rocco J. Crescenzo, DO, FACOI, Liza DeAnnuntis, Andrea Viquiera, Jorge E. Cortes, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4264.
https://doi.org/10.1182/blood-2018-99-110152
Published: 2018
Journal Articles

An Indirect Comparison between Bosutinib, Nilotinib and Dasatinib in First-Line Chronic Phase Chronic Myeloid Leukemia

Bogdan Muresan, MSc, Carla M. Mamolo, PhD, Joseph C Cappelleri, PhD MPH, MS, Rocco J. Crescenzo, MD, Eric Leip, PhD, Andrea Viqueira, MD, Bart Heeg, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1742.
https://doi.org/10.1182/blood-2018-99-114827
Published: 2018
Journal Articles

Comparison of Cure Rates between Gemtuzumab Ozogamicin Plus Standard of Care Chemotherapy Vs Standard of Care Alone in Patients with Newly Diagnosed Acute Myeloid Leukemia

Bogdan Muresan, MSc, Carla M. Mamolo, PhD, Joseph C Cappelleri, PhD MPH, MS, Ruth Mokgokong, Athina Palaka, Robert K. Hills, MA, DPhil, MSc, Nicholas Latimer, PhD, Bart Heeg, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2712.
https://doi.org/10.1182/blood-2018-99-110800
Published: 2018
Journal Articles

Budget Impact of First-Line Bosutinib for Chronic Phase Chronic Myeloid Leukemia on a US Health Plan

Verna L Welch, PhD MPH, CPEHR, CPHIMS, Peter Quon, MPH, Denise Zou, Jennifer Uyei, PhD MPH, Sherry Wu, MPH, Ying Xiao, Carla M. Mamolo, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5834.
https://doi.org/10.1182/blood-2018-99-110544
Published: 2018
Journal Articles

Cross-Sectional Survey of Symptoms and Health-Related Quality of Life of Adults with De Novo Acute Myeloid Leukemia (AML) in Clinical Practice

Carla M. Mamolo, Joseph C. Cappelleri, PhD MPH, MS, Caroline J. Hoang, PhD, Ruth Kim, Anna Hadfield, Chloe Middleton, Alex Rider, Roland B. Walter, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5660.
https://doi.org/10.1182/blood.V130.Suppl_1.5660.5660
Published: 2017
Journal Articles

Comparative Efficacy and Safety of Gemtuzumab Ozogamicin (GO) Plus Daunorubicin-Cytarabine Combination and Comparators As Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia

Ajibade Ashaye, Zarmina S. Khankhel, Yingxin Xu, Kyle Fahrbach, PhD, Ruth Mokgokong, Michelle Orme, Kathryn Lang, Joseph C. Cappelleri, PhD MPH, MS, Carla M. Mamolo
Journal: Blood
Blood (2017) 130 (Supplement 1): 2103.
https://doi.org/10.1182/blood.V130.Suppl_1.2103.2103
Published: 2017